Merrimack Pharmaceuticals, Inc. (MACK) Dividends
Dividend Yield and Dividend History Highlights
- MACK has a compound annual growth rate of its cash flow of -0.32%, higher than about 3.05% stocks in our dividend set.
- MACK has an EBITDA to net debt ratio of -131,000; for context, that's better than 2.69% stocks in our set (note that its net debt is negative, meaning it has more cash than debt).
- If you want to include this stock in your dividend portfolio, here are some dividend stocks that are NOT correlated with MACK that may be suitable potential portfolio mates: GAIA, HMG, ROP, SHLX and MUSA.
MACK does not currently pay a dividend. If the company does initiate a dividend payout, we'll add their payout info and history here.
In the mean time, you can check out our list of High Yield Dividend Stocks.